| Juliette Gerardo, MD | |
|
2315 Stockton Blvd, Sacramento, CA 95817-2201 | |
| (916) 734-2011 | |
| Not Available |
| Full Name | Juliette Gerardo |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 2315 Stockton Blvd, Sacramento, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023646361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 186657 (California) | Primary |
| Entity Name | Regents Of The Univ Of Ca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892 |
News Archive
Emerging Healthcare Solutions, Inc. is pleased to announce the execution of an exclusive option agreement with ThromboVision, Inc. ThromboVision, a Houston-based healthcare diagnostics company committed to enabling people to lead longer and healthier lives, has developed and patented T-Guide®, a new cutting-edge diagnostic test to assist medical professionals with the treatment of heart disease.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed to create a seamless supply chain to accelerate cell and gene therapy development and commercialsation.
Our gut microbiomes-the bacteria that live in our digestive tract-play major roles in our health. Scientists around the world are studying therapies that manipulate the microbiome, including probiotics (such as live bacterial cultures in yogurt), prebiotics (edible fibers meant to promote beneficial bacteria), antibiotics and transplants of microbes from healthy people.
› Verified 3 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952998973 PECOS PAC ID: 8022922475 Enrollment ID: O20031118001149 |
News Archive
Emerging Healthcare Solutions, Inc. is pleased to announce the execution of an exclusive option agreement with ThromboVision, Inc. ThromboVision, a Houston-based healthcare diagnostics company committed to enabling people to lead longer and healthier lives, has developed and patented T-Guide®, a new cutting-edge diagnostic test to assist medical professionals with the treatment of heart disease.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed to create a seamless supply chain to accelerate cell and gene therapy development and commercialsation.
Our gut microbiomes-the bacteria that live in our digestive tract-play major roles in our health. Scientists around the world are studying therapies that manipulate the microbiome, including probiotics (such as live bacterial cultures in yogurt), prebiotics (edible fibers meant to promote beneficial bacteria), antibiotics and transplants of microbes from healthy people.
› Verified 3 days ago
| Entity Name | Emergency Medicine Physician Partners Of El Dorado County Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619278660 PECOS PAC ID: 1456530153 Enrollment ID: O20110127000352 |
News Archive
Emerging Healthcare Solutions, Inc. is pleased to announce the execution of an exclusive option agreement with ThromboVision, Inc. ThromboVision, a Houston-based healthcare diagnostics company committed to enabling people to lead longer and healthier lives, has developed and patented T-Guide®, a new cutting-edge diagnostic test to assist medical professionals with the treatment of heart disease.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed to create a seamless supply chain to accelerate cell and gene therapy development and commercialsation.
Our gut microbiomes-the bacteria that live in our digestive tract-play major roles in our health. Scientists around the world are studying therapies that manipulate the microbiome, including probiotics (such as live bacterial cultures in yogurt), prebiotics (edible fibers meant to promote beneficial bacteria), antibiotics and transplants of microbes from healthy people.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juliette Gerardo, MD 4150 V Street Patient Support Services Bldg, Suite 2100, Sacramento, CA 95817 Ph: () - | Juliette Gerardo, MD 2315 Stockton Blvd, Sacramento, CA 95817-2201 Ph: (916) 734-2011 |
News Archive
Emerging Healthcare Solutions, Inc. is pleased to announce the execution of an exclusive option agreement with ThromboVision, Inc. ThromboVision, a Houston-based healthcare diagnostics company committed to enabling people to lead longer and healthier lives, has developed and patented T-Guide®, a new cutting-edge diagnostic test to assist medical professionals with the treatment of heart disease.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed to create a seamless supply chain to accelerate cell and gene therapy development and commercialsation.
Our gut microbiomes-the bacteria that live in our digestive tract-play major roles in our health. Scientists around the world are studying therapies that manipulate the microbiome, including probiotics (such as live bacterial cultures in yogurt), prebiotics (edible fibers meant to promote beneficial bacteria), antibiotics and transplants of microbes from healthy people.
› Verified 3 days ago
Elizabeth Johnson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 | |
Timothy Sturgill, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Hospital Dr, Sacramento, CA 95823 Phone: 330-493-4443 | |
Jon Haynes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Mark Portman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd., Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Dr. John Ray Richards, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Pssb 2100 Emergency Medicine, Sacramento, CA 95817 Phone: 916-734-1537 Fax: 916-734-7950 | |
Kerilee Wenker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2801 L St, Sacramento, CA 95816 Phone: 916-454-2222 |